The anti-clot treatment scale (ACTS): validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia

• Published in: Health and quality of life outcomes Vol. 18; no. 1; pp. 1 - 215
• Main Authors: Shilbayeh, Sireen Abdul Rahim, Ibrahim, Alnada Abdalla
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 06.07.2020; BioMed Central; BMC
• Subjects: Analysis; Anticoagulants; Arabic version; Correlation coefficient; Correlation coefficients; Criteria; Factor analysis; Health care facilities; Health services; Information management; Medical centers; Medical law; Medical research; Oral anticoagulant; Patient compliance; Patient satisfaction; Patient-reported outcomes; Patients; Psychometric validation; Quality of life; Questionnaires; Reliability analysis; Studies; Therapy; Thromboembolism; Treatment satisfaction; Validity; Warfarin; Saudi Arabia
• ISSN: 1477-7525; 1477-7525
• DOI: 10.1186/s12955-020-01471-4

Long-term anticoagulation therapy, particularly with warfarin, is usually associated with poor adherence and low patient satisfaction. However, previous studies have highlighted the possibility that individual perceptions of warfarin differ according to cultural practices. This study validated the psychometric properties of the translated Arabic version of the Anti-Clot Treatment Scale (ACTS) for patients on warfarin therapy in Saudi Arabia. A cross-sectional multicenter study was conducted at the three main medical centers in Riyadh. Stratified sampling was employed to recruit Arabic-speaking patients who had been taking warfarin for a minimum of 3 months for any indication. The patients completed the specific ACTS along with the generic Treatment Satisfaction Questionnaire for Medication (TSQM 1.4) at two clinic visits. The psychometric performance of the ACTS was evaluated using well-established criteria: feasibility, reliability, and validity. One hundred thirty-six patients participated in the study (mean age: 50.68 [+ or -] 14.6 years; range: 19-97). Overall, the patients reported moderate Burdens and Benefits scores (44 [+ or -] 9.9 and 11.92 [+ or -] 2.4, respectively) compared to the reference range for each subscale (12-60 and 3-15, respectively); however, they reported lower Burdens scores than other populations. Consistent with the original ACTS validation study, the criteria for acceptability (data targeting, floor/ceiling effects, and skewness) were satisfied; in fact, the Arabic version exhibited better item- and scale-level distributions of data than versions in other languages. The ACTS subscales also demonstrated satisfactory test-retest reliability with significant intraclass correlation coefficients ((ICC [greater than or equai to] 0.5); p < 0.001) and good internal consistency (all Cronbach's alpha values exceeded 0.7). Exploratory factor analysis supported the 2-factor loading model. Interestingly, the Arabic version exhibited greater convergent validity with the TSQM subdomains (r = 0.61). This study provides convincing evidence that the Arabic versions of both the ACTS Burdens and ACTS Benefits scales are equivalent to other versions in terms of psychometric performance, as measured using reliability and validity criteria. These properties support the great potential of the Arabic ACTS to accurately reflect patient satisfaction, identify aspects of treatment that need improvement in clinical practice, and compare treatment satisfaction across different anticoagulant therapies or cultures in research.